Eagle Meds Services
Augtyro (repotrectinib)
Available to sourceHuman Prescription DrugOncology & Specialty

Augtyro (repotrectinib)

160 mg/1 · Capsule
By E.R. Squibb & Sons, L.L.C.
NDC
0003-4160
Route
Oral
Therapeutic class
Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor , Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 14 CAPSULE in 1 BOTTLE (0003-4160-14)NDC 0003-4160-14Available to order
  • 60 CAPSULE in 1 BOTTLE (0003-4160-60)NDC 0003-4160-60Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Augtyro (repotrectinib)
NDC 0003-4160
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source